{"nct_id":"NCT02583594","title":"A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2015-12-06","start_date_type":"ACTUAL","primary_completion_date":"2016-03","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SNY"]}